Hypotension-Avoidance Versus Hypertension-Avoidance Strategies in Noncardiac Surgery : An International Randomized Controlled Trial
- PMID: 37094336
- DOI: 10.7326/M22-3157
Hypotension-Avoidance Versus Hypertension-Avoidance Strategies in Noncardiac Surgery : An International Randomized Controlled Trial
Abstract
Background: Among patients having noncardiac surgery, perioperative hemodynamic abnormalities are associated with vascular complications. Uncertainty remains about what intraoperative blood pressure to target and how to manage long-term antihypertensive medications perioperatively.
Objective: To compare the effects of a hypotension-avoidance and a hypertension-avoidance strategy on major vascular complications after noncardiac surgery.
Design: Partial factorial randomized trial of 2 perioperative blood pressure management strategies (reported here) and tranexamic acid versus placebo. (ClinicalTrials.gov: NCT03505723).
Setting: 110 hospitals in 22 countries.
Patients: 7490 patients having noncardiac surgery who were at risk for vascular complications and were receiving 1 or more long-term antihypertensive medications.
Intervention: In the hypotension-avoidance strategy group, the intraoperative mean arterial pressure target was 80 mm Hg or greater; before and for 2 days after surgery, renin-angiotensin-aldosterone system inhibitors were withheld and the other long-term antihypertensive medications were administered only for systolic blood pressures 130 mm Hg or greater, following an algorithm. In the hypertension-avoidance strategy group, the intraoperative mean arterial pressure target was 60 mm Hg or greater; all antihypertensive medications were continued before and after surgery.
Measurements: The primary outcome was a composite of vascular death and nonfatal myocardial injury after noncardiac surgery, stroke, and cardiac arrest at 30 days. Outcome adjudicators were masked to treatment assignment.
Results: The primary outcome occurred in 520 of 3742 patients (13.9%) in the hypotension-avoidance group and in 524 of 3748 patients (14.0%) in the hypertension-avoidance group (hazard ratio, 0.99 [95% CI, 0.88 to 1.12]; P = 0.92). Results were consistent for patients who used 1 or more than 1 antihypertensive medication in the long term.
Limitation: Adherence to the assigned strategies was suboptimal; however, results were consistent across different adherence levels.
Conclusion: In patients having noncardiac surgery, our hypotension-avoidance and hypertension-avoidance strategies resulted in a similar incidence of major vascular complications.
Primary funding source: Canadian Institutes of Health Research, National Health and Medical Research Council (Australia), and Research Grant Council of Hong Kong.
Conflict of interest statement
Comment in
-
In noncardiac surgery, hypotension- vs. hypertension-avoidance strategies did not differ for 30-d major vascular complications.Ann Intern Med. 2023 Aug;176(8):JC90. doi: 10.7326/J23-0056. Epub 2023 Aug 1. Ann Intern Med. 2023. PMID: 37523699
-
Hypotension-Avoidance Versus Hypertension-Avoidance Strategies in Noncardiac Surgery.Ann Intern Med. 2023 Nov;176(11):eL230323. doi: 10.7326/L23-0323. Ann Intern Med. 2023. PMID: 37983798 No abstract available.
Similar articles
-
Rationale and design of the PeriOperative ISchemic Evaluation-3 (POISE-3): a randomized controlled trial evaluating tranexamic acid and a strategy to minimize hypotension in noncardiac surgery.Trials. 2022 Jan 31;23(1):101. doi: 10.1186/s13063-021-05992-1. Trials. 2022. PMID: 35101083 Free PMC article. Clinical Trial.
-
Effect of a Perioperative Hypotension-Avoidance Strategy Versus a Hypertension-Avoidance Strategy on the Risk of Acute Kidney Injury: A Clinical Research Protocol for a Substudy of the POISE-3 Randomized Clinical Trial.Can J Kidney Health Dis. 2022 Jan 7;9:20543581211069225. doi: 10.1177/20543581211069225. eCollection 2022. Can J Kidney Health Dis. 2022. PMID: 35024154 Free PMC article.
-
A sub-study of the POISE-3 randomized trial examined effects of a perioperative hypotension-avoidance strategy versus a hypertension-avoidance strategy on the risk of acute kidney injury.Kidney Int. 2024 Oct 25:S0085-2538(24)00717-8. doi: 10.1016/j.kint.2024.10.007. Online ahead of print. Kidney Int. 2024. PMID: 39490985
-
Optimal perioperative management of arterial blood pressure.Integr Blood Press Control. 2014 Sep 12;7:49-59. doi: 10.2147/IBPC.S45292. eCollection 2014. Integr Blood Press Control. 2014. PMID: 25278775 Free PMC article. Review.
-
Effect of hypotension prediction index in the prevention of intraoperative hypotension during noncardiac surgery: A systematic review.J Clin Anesth. 2022 Dec;83:110981. doi: 10.1016/j.jclinane.2022.110981. Epub 2022 Oct 13. J Clin Anesth. 2022. PMID: 36242978 Review.
Cited by
-
Perioperative myocardial injury.BJA Educ. 2024 Oct;24(10):352-360. doi: 10.1016/j.bjae.2024.06.001. Epub 2024 Aug 1. BJA Educ. 2024. PMID: 39484008 Review. No abstract available.
-
[Cardiovascular management of patients undergoing noncardiac surgery].Herz. 2024 Dec;49(6):479-488. doi: 10.1007/s00059-024-05274-x. Epub 2024 Oct 21. Herz. 2024. PMID: 39432064 Review. German.
-
Impact of tranexamic acid use in total hip replacement patients: A systematic review and meta-analysis.J Orthop. 2024 Aug 13;60:125-133. doi: 10.1016/j.jor.2024.08.004. eCollection 2025 Feb. J Orthop. 2024. PMID: 39411506 Review.
-
Impact of Preanesthetic Blood Pressure Deviations on 30-Day Postoperative Mortality in Non-Cardiac Surgery Patients.J Korean Med Sci. 2024 Sep 9;39(35):e241. doi: 10.3346/jkms.2024.39.e241. J Korean Med Sci. 2024. PMID: 39252683 Free PMC article.
-
Effects of different doses of alfentanil on cardiovascular response to rapid sequence intubation in elderly patients: a parallel-controlled randomized trial.BMC Anesthesiol. 2024 Aug 13;24(1):290. doi: 10.1186/s12871-024-02663-x. BMC Anesthesiol. 2024. PMID: 39138407 Free PMC article. Clinical Trial.
Publication types
MeSH terms
Substances
Associated data
Grants and funding
LinkOut - more resources
Full Text Sources
Medical